Cannabis Science Inc (OTCMKTS:CBIS) has made some moves to make sure it improves its financial position. The company recently acquired the services of Derwin A. Wallace to assist the company with financial and investor relations. Mr. Wallace aims to develop a financial and investor relations program. The program would expand the company’s financial communications throughout the institutional and retail investment communities. The program would utilize the services of research analysts to develop a strong connection with the company’s shareholders and keep them up to date with recent developments. The company expects that it would be able to speed up results from individual projects and quickly generate operational cash flow, when the need arises.
There are a number of projects planned by the company, in the pipeline. It is expected that increasing public awareness about these projects would help the company gain the trust of its investors. Additionally, keeping the investors informed through official releases would mean that the company would be able to perform better in the market. There is a large increase in revenue projected by the company, in accordance with these projects. The company also stated that this it is just scratching the surface of the potential growth that it expects to experience in the coming days.
The company had also taken part in the Premier Global Cannabis Event, where it was able to showcase its products to potential customers. The company later reported that there is a strong customer interest in the company’s products in Europe, which just might help it pursue its long line of projects further. Currently, the main aim of the company is to generate capital between $5 million and $25 million. This sum, the company reported, includes the costs of its various projects. Further successes might also allow the company to generate enough revenues to expand its customer base into Europe. If this happens, it would be one of the most profitable moves by the company. Many companies have been targeting Europe as its center of operations, mainly due to flexible laws compare to the US and CBIS just might be another name on that list.
Cannabis Science Inc (OTCMKTS:CBIS) closed at $0.0408, dropping by 1.09% yesterday.